Bob D. Brown
Director
Business Development
Dicerna Pharmaceuticals
United States of America
Biography
Bob holds a Ph.D. in molecular biology from the University of California, Berkeley, and B.S. degrees in chemistry and biology from the University of Washington. Bob Brown, Ph.D., joined Dicerna as senior vice president, research in 2008. Prior to joining Dicerna, he had a long career at Genta, where he was vice president, research and technology and had more than 75 issued patents and patent applications. While at Genta, Bob became one of the only R&D executives in the biotechnology industry to follow a systemically administered oligonucleotide therapeutic (Genasense™) from the research bench through Phase 1, 2 and 3 clinical trials and NDA review. He worked directly with clinicians and study investigators on trial design, execution and interpretation of results. In addition to his roles at Genta, Bob was co-founder and vice president of research and development at Oasis Biosciences Bob holds a Ph.D. in molecular biology from the University of California, Berkeley, and B.S. degrees in chemistry and biology from the University of Washington. Bob Brown, Ph.D., joined Dicerna as senior vice president, research in 2008. Prior to joining Dicerna, he had a long career at Genta, where he was vice president, research and technology and had more than 75 issued patents and patent applications. While at Genta, Bob became one of the only R&D executives in the biotechnology industry to follow a systemically administered oligonucleotide therapeutic (Genasense™) from the research bench through Phase 1, 2 and 3 clinical trials and NDA review. He worked directly with clinicians and study investigators on trial design, execution and interpretation of results. In addition to his roles at Genta, Bob was co-founder and vice president of research and development at Oasis Biosciences
Research Interest
His research interest in Business and Management
